Researchers discovered a genetic mutation in troponin T that disrupts the heart's ability to increase pumping force when needed. This limits the heart's capacity to pump additional blood around the body, potentially leading to severe consequences for individuals with hypertrophic cardiomyopathy.
A study published in the Journal of Experimental Medicine found that a signaling protein called interleukin-1 receptor accessory protein (IL1RAP) plays a critical role in driving the development and progression of acute myeloid leukemia. IL1RAP amplifies multiple key pathways, making it a promising target for treatment.
Researchers discovered colon cancers are composed of two different cell types that can replace each other when one is killed. Targeting both cell populations simultaneously showed strong repressive effects on tumor cell proliferation and increased cell death, resulting in slower tumor growth and prolonged survival times.
A new study found that cells with abnormal centrosomes are present before they transform into cancer cells in patients with Barrett's esophagus. Centrosome amplification was found to be a hallmark of human tumors and may contribute to the initiation and progression of various cancers.
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, but found that zoledronic acid inhibits UGT8 and prevents its spread. The drug may offer a new hope for treating this aggressive form of breast cancer, which is largely untreatable.
Researchers discovered that a multiple sclerosis drug can mitigate the painful side effect of cancer treatment bortezomib. Fingolimod, an approved multiple sclerosis medication, blocks the production of molecules causing nerve damage and alleviates neuropathic pain.
Researchers discovered that inhibiting CDK2 protects mice and rats from noise- or drug-induced hearing loss. Kenpaullone, a CDK2 inhibitor, shows significant clinical potential in treating noise-induced hearing loss.
Researchers have found that dermal macrophages capture and recapture tattoo pigment, allowing for continuous maintenance of tattoos. This process can be disrupted by killing off macrophages, potentially improving the effectiveness of laser surgery in removing unwanted tattoos.
In a groundbreaking study, researchers from the Cleveland Clinic Lerner Research Institute successfully reversed the formation of amyloid plaques in mice with Alzheimer's disease by gradually depleting the enzyme BACE1. This approach improved cognitive function and had significant benefits for the animals' health.
A recent study published in the Journal of Experimental Medicine reveals that a common CLL treatment may be less effective in patients with a specific protein marker. Combining ibrutinib with drugs blocking this protein could prevent tumor cells from sheltering in lymphoid organs, leading to improved patient outcomes.
The study found that the Pacific midshipman's swimbladder muscles release and pump calcium ions at a much slower rate than those of other fish, allowing it to sustain an hour-long mating call. This low level of calcium release reduces metabolic demands and enables the muscle fibers to contract with sufficient force.
A team of researchers identified a crucial region in Numb that binds and inhibits Mdm2, stabilizing p53 levels. This interaction is key to understanding the regulation of p53 in breast cancers, which tend to retain a functional p53 gene.
A study published in Journal of Cell Biology identifies SUV420H2 as an epigenetic orchestrator of pancreatic cancer cells' aggressive behavior. Reducing SUV420H2 levels makes pancreatic cancer cells more vulnerable to existing therapies.
Researchers discovered that chemotherapy can stimulate tumor growth by inducing an inflammatory reaction in the body. Resolvins, a family of molecules, have been found to suppress this response, suggesting new ways to enhance cancer therapy effectiveness.
Researchers in Germany have demonstrated that temporarily preventing hematopoietic stem cells from dying can improve HSC transplantation outcomes. By inhibiting apoptosis, HSCs can establish themselves in the bone marrow and produce healthy blood cells more effectively.
Researchers have found that Zika virus preferentially infects and kills glioblastoma stem cells compared to other cell types. A mutant strain of the virus shows promise in slowing tumor growth and extending lifespan when combined with chemotherapy, offering a new potential treatment for brain cancer.
Researchers found that impaired lysosome transport contributes to protein aggregate buildup in brains of mice with Alzheimer's. Developing ways to restore lysosome transport could represent a new therapeutic approach.
Researchers have developed a new method to generate specific human antibodies in the laboratory using nanoparticles. This technique can produce high-affinity antibodies within days, offering potential for rapid therapeutic antibody production and accelerated vaccine development.
Researchers found that breaking a barrier to autoimmune disease also enables the production of antibodies capable of neutralizing HIV-1. The study, published in The Journal of Experimental Medicine, suggests a potential new approach for developing an HIV vaccine.
Researchers at The Ohio State University have discovered that blows to the head can cause small swellings along the length of neuronal axons. This finding provides novel mechanistic insights into the initial stage of a new type of neuronal plasticity in health and disease.
Researchers found that gut bacteria can limit Listeria growth and prevent infection in immunocompromised mice. Probiotic bacteria species were identified as protective against Listeria infections in laboratory cultures.
Researchers discovered a receptor protein on heart cells that promotes chronic heart failure, and found that inhibiting it could help treat the disease. The study suggests that targeting this protein could lead to new treatments for millions of people affected by chronic heart failure.
A recent study reveals that microRNA-223 plays a crucial role in regulating intestinal inflammation in inflammatory bowel disease. Synthetic versions of this microRNA can reduce inflammation in mice and may hold promise as a future therapy for IBD patients.
Researchers at the University of Maryland have identified how Pseudomonas aeruginosa uses tension-activated membrane channels to resist osmotic downshocks. The bacterium's ability to survive sudden changes in water content is crucial for its persistence in various environments.
A new detection method allows for the measurement of interferon- protein levels in patient samples, providing novel insights into disease-causing pathways and potential biomarkers for treatment monitoring. Elevated interferon- levels were found in autoimmune diseases such as SLE and dermatomyositis.
Researchers discovered that anthrax spores stimulate the host immune system by activating a distinct set of immune sensors that don't recognize the active form of Bacillus anthracis. This triggers an unfavorable immune response, hindering the body's fight against the bacterium after germination.
Researchers have developed a transgenic mouse that can help identify new influenza virus strains with the potential to cause a global pandemic. The mouse expresses human MxA protein, which is thought to target influenza A viruses, and has shown resistance to avian but susceptibility to human flu viruses.
Researchers identified secretogranin III as a potential therapeutic target for preventing diabetic retinopathy and retinopathy of prematurity. Inhibiting this protein may reduce vision loss in both conditions.
Researchers discovered that a metabolic enzyme called AKR1B1 drives aggressive basal-like breast cancer progression. An inhibitor of this enzyme, epalrestat, was shown to block the growth and metastasis of human basal-like breast cancer cells.
Researchers at Rockefeller University Press discovered that tumor suppressor protein RUNX1 can promote AML in some cases, particularly when combined with mutant FLT3. Targeting RUNX1 may be an effective treatment for certain AML patients, potentially offering a promising therapeutic strategy.
Researchers at Cold Spring Harbor Laboratory have discovered that Importin-11 protects the anti-cancer protein PTEN from degradation by transporting it into the cell nucleus. This discovery suggests that the loss of Importin-11 may destabilize PTEN, leading to cancer development in lung, prostate, and other cancers.
Researchers at Boston Children's Hospital have identified a new cause of brain defects in tuberous sclerosis complex (TSC) patients. The study reveals that a protein called connective tissue growth factor (CTGF) impedes oligodendrocyte development and myelination in the brains of TSC patients.
Researchers found inhibiting metabolic enzyme phosphoglycerate mutase 1 (PGAM1) sensitizes tumors to Olaparib, expanding cancer treatment options. Combining PGAM1 inhibitors with Olaparib suppresses tumor growth in BRCA-proficient cancers.
Researchers discovered that replacing missing gut bacteria or restoring a key metabolite called inosine could help treat children with IPEX syndrome, an often fatal autoimmune disease. The study found that probiotic Lactobacillus reuteri and A2A receptor agonists inhibited T cell-mediated autoimmunity, extending the animals' life span.
Researchers discovered that Huntington's disease affects muscle maturation, leading to disrupted skeletal muscle function and potentially improving motor symptoms. The study suggests targeting skeletal muscle tissue may provide a new opportunity to improve patient care.
Researchers discovered that low-dose chemotherapy regimens can prevent the secretion of proteins by fibroblast cells surrounding tumors, reducing the likelihood of tumor recurrence. Mice with breast or pancreatic cancer treated with these regimens survived longer than those receiving high-dose chemotherapy.
Researchers have discovered that mice infected with the common gut parasite Tritrichomonas muris are at an increased risk of developing inflammatory colitis. The study highlights the need for a better understanding of cross-kingdom interactions between host and protozoa within the gastrointestinal tract.
Researchers at Stanford University have identified several biological markers that can measure the progression of Huntington's disease in non-neural tissues. The team found that levels of mitochondrial DNA were elevated in plasma samples from patients with the disease, and P110 treatment corrected these levels.
Researchers found that adrenergic nerves control the daily cycle of immune cell trafficking, with T and B cells accumulating in lymph nodes during the day. This circadian pattern regulates the immune response, making mice more susceptible to infection when injected with antigens at night.
Scientists have discovered a new target to combat severe and fatal allergic reactions by identifying a molecular motor that controls the release of inflammatory factors. Researchers found that depleting this motor reduces mast cell granule transport and release, potentially leading to new treatment options for anaphylaxis.
Research suggests that spinal cord injuries alter the type of bacteria living in the gut, exacerbating neurological damage and impairing recovery. Probiotics may counteract these changes, aiding patients' recovery from spinal cord injuries by activating regulatory T cells and promoting neuronal growth.
A SickKids-led project explores the effects of severe malnutrition on children's livers, finding that dysfunctional mitochondria and peroxisomes contribute to impaired nutrient utilization. The study identifies a key gene, PEX2, involved in peroxisome loss during starvation.
Researchers have discovered that secondary infection with MRSA often kills influenza patients due to altered antibacterial response of white blood cells. The flu virus can cause extensive lung damage by suppressing the ability of macrophages and neutrophils to kill bacteria, leading to lethal inflammation.
Researchers have developed a new approach to limit side effects of stem cell transplants by stimulating the formation of regulatory T cells in recipients. Pretreating mice with STAR2 protein protected them from developing GvHD, while donor-derived cells retained their ability to kill recipient's tumor cells.
Researchers identified STN1 gene mutations as the cause of Coats plus syndrome, a telomeropathy that affects multiple tissues. The study found that cells with dysfunctional telomeres and decreased capacity to divide were characteristic of patients with Coats plus syndrome.
A study published in The Journal of General Physiology found that two specific mutations in the Cx26 protein cause distinct symptoms in KID Syndrome patients. Hemichannels containing the N14Y mutation showed lower ion conductance, while those with the N14K mutation were more stable and allowed robust ion conductance.
Researchers have discovered that enhancing mitochondrial transport along neuronal axons improves the ability of mouse nerve cells to repair themselves after injury. The study suggests potential new strategies for stimulating human neurons to regrow after damage or disease.
HUMIRA enhances the function of TNF in rheumatoid arthritis patients by increasing its expression on monocytes and promoting membrane-bound TNF-RII binding. This leads to the activation of anti-inflammatory T cells that can suppress inflammation.
Researchers successfully treated a patient with metastatic melanoma using a combined approach of immunotherapy, including IL-21-primed polyclonal CTL plus CTLA4 blockade. The treatment led to the complete disappearance of tumors and sustained disease-free status for five years.
Researchers discovered that heart muscle cell chromosomes rapidly erode after birth, limiting their ability to proliferate and replace damaged heart tissue. Maintaining telomere length may boost regenerative capacity, improving cardiac tissue recovery after a heart attack.